Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MEI Pharma, Inc. - Common Stock (NQ:MEIP)

6.860 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MEI Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Trades Cash For LTC
Via Stocktwits
These stocks have an unusual volume in today's session
On Monday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
US Stocks Likely To Open Higher Despite Trump Administration's 'Hard Deadline' Warning For Tariffs — Verizon, Domino's Pizza Earnings In Focus
U.S. stock futures were positive on Monday after ending mostly lower on Friday. Futures of major benchmark indices were higher. 
Via Benzinga
Topics Government
Why Is MEI Pharma Stock Soaring On Friday?
MEI Pharma, Inc. (NASDAQ:MEIP) stock is trading higher on Friday, with a session volume of 35.64 million compared to the average volume of 29.8K, as per data from Benzinga Pro. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Dow Falls Over 200 Points; 3M Earnings Top Views
Via Benzinga
Topics Stocks
MEI Pharma Announces $100M Placement To Initiate Litecoin Treasury Strategy: Retail Cheers Charlie Lee’s Addition To Company Board
MEI Pharma intends to use the funds to acquire the native cryptocurrency of the Litecoin blockchain, commonly referred to as “LTC”, which will serve as the company’s primary treasury reserve asset. 
Via Stocktwits
First Strategy, Now MEI Pharma: Litecoin Joins Bitcoin As Treasury Asset
MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group and 
Via Benzinga
US Stocks Mixed; American Express Posts Upbeat Q2 Results
Via Benzinga
MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange
From MEI Pharma, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position
From MEI Pharma, Inc.
Via Business Wire
Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week. 
Via Benzinga
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates. 
Via Benzinga
MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position
From MEI Pharma, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
MEI Pharma Reports Fiscal Year End 2024 Cash Position
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives
From MEI Pharma, Inc.
Via Business Wire
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
MEI Pharma to Consider Strategic Alternatives
From MEI Pharma, Inc.
Via Business Wire
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
From Glancy Prongay & Murray LLP
Via Business Wire
MEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024
MEIP stock results show that MEI Pharma beat analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace
MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum
From MEI Pharma, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.